戻る
Vicapsys Life Sciences Inc (VICP)価格
VICP 株価推移チャート
VICP 財務
Vicapsys Life Sciences Inc
$1.5
0%
$0
終値： Feb 12, 16:00:00 GMT-5
$1.5
0%
$0
アフターマーケット：Feb 12, 20:00:00 GMT-5
収入
貸借対照表
現金の流れ
年次
四半期
VICP 収入
金額は百万米ドル単位。会計年度は2月から1月まで。
Follow-Up Questions
Vicapsys Life Sciences Incの主要な財務諸表は何ですか？
VICPの主要な財務比率は何ですか？
Vicapsys Life Sciences Incの収益はセグメントまたは地域別にどのように分けられていますか？
Vicapsys Life Sciences Incは収益を上げていますか？
Vicapsys Life Sciences Incに負債はありますか？
Vicapsys Life Sciences Incの発行済株式数は何株ですか？
主要データ
前終値
$1.5
始値
$1.5
当日レンジ
$1.5 - $1.5
52週レンジ
$1 - $2.45
取引高
225
平均取引高
13
1株当たり利益(TTM)
--
配当利回り
--
時価総額
$48.5M
VICPとは何ですか？
Vicapsys Life Sciences, Inc. is a development stage biotechnology company, which advances proprietary localized immune modulator. The company is headquartered in Cumming, Georgia and currently employs 2 full-time employees. The company went IPO on 2001-07-11. VICAPSYN is the Company’s product line that is applied to transplantation therapies and related stem-cell applications in the transplantation field. The lead product candidate embodiment in transplantation therapy to treat Type 1 Diabetes (T1D) is an encapsulated human islet cell cluster that is intended to restore normal glucose control when implanted into the peritoneal cavity of a patient. The company also develops another product candidate line based on CXCL12 with the trade name of VYBRIN. The clinical applications of VYBRIN are being explored in several areas, including prevention of post-surgical adhesions in abdominal surgery and others.